Literature DB >> 1913062

Cystine stones: the impact of new treatment.

X Martin1, M Salas, M Labeeuw, N Pozet, A Gelet, J M Dubernard.   

Abstract

The hardness and frequent recurrence of cystine stones present a special challenge to the urologist. In this study, 15 cystinuric patients (11 males, 4 females; mean age 36 years, range 17-54) were treated and followed up over a period of 30 months (range 2-40). Most patients had previous history of open surgery. The diagnosis of cystinuria was confirmed by metabolic studies and infrared spectrometry of stones. Over the follow-up period recurrence was observed in 23 instances in 11 patients, leading to 38 "stone treatments" on 74 cystine stones. The percutaneous approach was used alone in 9 cases and in association with extracorporeal shock wave lithotripsy (ESWL) in 9 cases. ESWL was used alone in 18 cases. Medical treatment included high fluid intake, alkalinisation and Thiola (tiopronin, N-(2-mercaptopropionyl)glycine) in 6 patients. The overall stone-free rate assessed 3 months after treatment was 44.7%, which compares poorly with the rate for non-cystine stones. The recurrence rate is very high and instrumental treatment should not therefore be used excessively; it is indicated only for stones that are symptomatic or refractory to intensive medical therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913062     DOI: 10.1111/j.1464-410x.1991.tb15313.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  2 in total

1.  Extracorporeal shock wave lithotripsy for cystine urolithiasis in children: outcome and complications.

Authors:  Andjelka Slavković; Miladin Radovanović; Zlatko Sirić; Marina Vlajković; Vladisav Stefanović
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy.

Authors:  Samuel C Kim; Erin K Burns; James E Lingeman; Ryan F Paterson; James A McAteer; James C Williams
Journal:  Urol Res       Date:  2007-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.